✦ LIBER ✦

Does adjuvant radiotherapy have any place in treatment of early breast cancer?

✍ Scribed by T.F. Nealon Jr.; J. Gillooley; C.E. Grossi; A. Nkongho; C. Nealon; R. Ward; G. Schwarz

Publisher: Elsevier Science
Year: 1981
Tongue: English
Weight: 93 KB
Volume: 7
Category: Article
ISSN: 0360-3016
DOI: 10.1016/0360-3016(81)90286-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Does adjuvant radiotherapy have a role i

Does adjuvant radiotherapy have a role in the postmastectomy management of patients with operable breast cancer--revisited

✍ Robert W. Edland 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 103 KB

Feasibility of concurrent adjuvant chemo

Feasibility of concurrent adjuvant chemotherapy and radiotherapy after breast-conserving surgery in early breast cancer

✍ Sehwan Han; Juree Kim; Seungchang Sohn; Geum-Hee Kwak; Ji-Young Kim; Kyeongmee P 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB

The place of radiotherapy in the managem

The place of radiotherapy in the management of early breast cancer. A report of two clinical trials

✍ Mary P. Cole 📂 Article 📅 1964 🏛 John Wiley and Sons 🌐 English ⚖ 437 KB 👁 2 views

Disparities in the application of adjuva

Disparities in the application of adjuvant radiotherapy after breast-conserving surgery for early stage breast cancer : Impact on overall survival

✍ Anthony E. Dragun; Bin Huang; Thomas C. Tucker; William J. Spanos 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 271 KB 👁 1 views

Anastrozole alone or in combination with

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer : Results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update analyses

✍ The ATAC (Arimidex; Tamoxifen Alone or in Combination) Trialists' Group 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB 👁 2 views

## Abstract ## BACKGROUND The first analysis of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial (median follow‐up, 33 months) demonstrated that in adjuvant endocrine therapy for postmenopausal patients with early‐stage breast cancer, anastrozole was superior to tamoxifen in terms of d